Please login to the form below

Not currently logged in
Email:
Password:

gram-negative bacteria

This page shows the latest gram-negative bacteria news and features for those working in and with pharma, biotech and healthcare.

UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme

UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme

The antibiotic treats infections caused by aerobic Gram-negative bacteria. Shionogi’s novel antibiotic Fetcroja has been selected for inclusion in a pilot subscription reimbursement scheme, launched by the UK’s ... Fetcroja was launched in the UK in

Latest news

More from news
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    using Warp's SMART and genome mining platforms for the discovery of oncology therapeutics and antibiotics targeting Gram negative bacteria.

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    270. Discuva / Roche. Collaboration. Antibiotics to target multi-drug resistant Gram negative bacteria.

  • Pharma deals during February 2014 Pharma deals during February 2014

    BATON studies in colorectal cancer and metastatic triple negative breast cancer. ... In the meantime, Roche's pRED group will make use of Discuva's development technology, which uses gene sequencing and bioinformatics to identify targets for multi-drug

  • Pharma deals during March 2013 Pharma deals during March 2013

    This combined intravenous therapy is currently undergoing phase III clinical trials as a potential first-line treatment for complicated intra-abdominal and urinary tract infections caused by certain Gram-negative bacteria, ... Astellas Pharma/ Cubist

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...